Clinical Trial

Focal Salvage Brachytherapy Study (FocaSaBra)

Study acronym: FocaSaBra
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 30, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this prospective phase II study is to evaluate the toxicity of salvage partial (focal) prostate brachytherapy in patients after prior radiotherapy (standard teleradiotherapy with / without brachytherapy, hypofractionated, self-reactive HDR / LDR brachytherapy) with local recurrence on the part of the prostate gland.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-01-27; most recent amendment 2025-04-28.
Trial Details
NCT Number NCT05715502
Lead Sponsor The Greater Poland Cancer Centre
Conditions Prostate Cancer
Enrollment 100 participants
Start Date 2022-05-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-30